Navigation Links
OxySure Systems Announces Supplier Agreement With Grainger
Date:3/15/2012

FRISCO, Texas, March 15, 2012 /PRNewswire/ -- OxySure® Systems, Inc. (OTCBB: OXYS) ("OxySure"), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology has announced the Company has entered into a Supplier Agreement ("Agreement") with W.W. Grainger, Inc. (NYSE: GWW) ("Grainger").

(Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO)

In terms of the Agreement, OxySure will supply its products to Grainger for sale, marketing and distribution through Grainger's platforms, which include Grainger's catalog, Grainger Parts, Grainger Sourcing, Grainger's national branch network, Grainger's web sites and other electronic and paper media, as well as the Grainger sales teams.

Founded in 1927, Grainger is North America's largest broad line supplier of maintenance, repair and operating (MRO) products, with 2011 sales of $8.1 billion and with expanding global operations.  Grainger serves more than two million active business and institutional customers in 157 countries, and is a valued and trusted partner for all their emergency MRO product needs. Grainger is a Fortune 100 company with 607 branches, 24 distribution centers and 18,500 team members.

"Our relationship with Grainger is a very important and logical next step as we forge ahead with our growth and expansion plans. We believe our products are an excellent fit in Grainger's Safety and Security category, and Grainger provides us an instant footprint that is formidable in reach and scope," said Julian Ross, the CEO of OxySure Systems, Inc.

About OxySure Systems, Inc.

OxySure Systems, Inc. is a Frisco, Texas-based medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other public settings. www.OxySure.com

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.

www.OxySure.com


'/>"/>
SOURCE OxySure Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OxySure Inks 5-Year Partnership With the City of Frisco to Place OxySure/AED Packages in Its Public Venues
2. OxySure(R) Aids Student in School Respiratory Arrest: WFAA Channel 8 News
3. Dehaier Medical Systems Schedules 2011 Fourth Quarter and Full Year Financial Results and Conference Call
4. South and Central America Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
5. Mevion Medical Systems Receives CE Marking Certification for the MEVION S250 Proton Therapy System
6. Pancreas-targeted siRNA In Vivo Transfection Kit from Altogen Biosystems
7. Varian Medical Systems Announces Agreement to Acquire InfiMed, Inc.
8. Varian Medical Systems to Exhibit X-Ray Tubes and Flat Panel Detector Technology Enhancements to Improve Digital Imaging at the ECR Annual Meeting
9. Four Rivers Software Systems Launches TMS 2012.5.5
10. Varian Medical Systems Receives FDA 510(k) Clearance for Use of Transponder to Monitor Motion During Radiotherapy Anywhere in Body
11. ECRI Institute Guides Hospital Decision-Makers in the Purchase of CT Scanning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, ... today unveiled a new store design to enhance ... of healthier food, health-focused products and expanded beauty ... to help customers discover new offerings. Together with ... next evolution of the customer experience at CVS ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):